Q Therapeutics, Inc. Financing Receivable, after Allowance for Credit Loss, Current
Q Therapeutics, Inc. had Financing Receivable, after Allowance for Credit Loss, Current of $27.74 thousand as of 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2012-11-13
- 2012-09-30: Financing Receivable, after Allowance for Credit Loss, Current $27.74K.
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-09-30 | $27.74K 10-Q · filed 2012-11-13 |